Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now ...

VOV.VN - Vietnam Vaccine JSC (VNVC) began administering the pneumococcal 15-valent conjugate vaccine (PCV15 or Vaxneuvance) ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today shared new preclinical data for ...

Crinetics Pharmaceuticals, Inc.’s CRNX share price has surged by 8.07%, which has investors questioning if this is right time to sell.

The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...

Detailed price information for Bolt Biotherapeutics Inc (BOLT-Q) from The Globe and Mail including charting and trades.

Topline pivotal Phase 3 firmonertinib data. ArriVent anticipates having topline firmonertinib monotherapy data from the event-driven global pivotal FURVENT Phase 3 (NCT05607550) study in 2025 and ...

Researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.

Serina Therapeutics, Inc.’s SER share price has surged by 9.23%, which has investors questioning if this is right time to ...

The Cancer Pioneers” has just dropped, giving audiences a moving first look at the groundbreaking new documentary that ...

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

Researchers developed a biomimetic nanovesicle that crosses the blood-brain barrier, degrades DNA repair proteins, and ...